期刊文献+

细胞焦亡在肝纤维化发生发展中的作用 被引量:3

Role of pyroptosis in the pathogenesis of hepatic fibrosis
下载PDF
导出
摘要 肝纤维化是肝脏对各种慢性肝损伤进行自我修复的一种可逆性病理反应,可发展为肝硬化、肝癌。细胞焦亡是有别于细胞凋亡、坏死的细胞新型程序性死亡方式,与肝纤维化发病密切相关。简述了细胞焦亡的概念、激活途径以及在肝星状细胞、肝实质细胞、Kupffer细胞、嗜酸性粒细胞中作用的最新研究进展,指出细胞焦亡可诱发肝脏炎症,过度活化肝星状细胞,促进肝纤维化发生、发展,为其临床诊疗提供了新的思路与潜在靶点。 Hepatic fibrosis is a reversible pathological reaction of the liver during the self-repair of various chronic liver injuries and can progress to liver cirrhosis and liver cancer.Pyroptosis is a new type of programmed cell death different from apoptosis and necrosis and is closely associated with the pathogenesis of hepatic fibrosis.This article reviews the latest research advances in the definition of pyroptosis,related activation pathways,and its role in hepatic stellate cells,hepatic parenchymal cells,Kupffer cells,and eosinophils,and it is pointed out that pyroptosis can induce liver inflammation,excessively activate hepatic stellate cells,and promote the development and progression of hepatic fibrosis,in order to provide new ideas and potential targets for clinical diagnosis and treatment.
作者 凡畅 吴芙蓉 张家富 姜辉 FAN Chang;WU Furong;ZHANG Jiafu(Clinical Research Center, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, China)
出处 《临床肝胆病杂志》 CAS 北大核心 2020年第5期1138-1140,共3页 Journal of Clinical Hepatology
基金 国家自然科学基金项目(81973648)。
关键词 肝硬化 细胞焦亡 病理过程 liver cirrhosis pyroptosis pathologic processes
  • 相关文献

参考文献11

二级参考文献64

  • 1Li-Kun Wang,Lu-Wen Wang,Xun Li,Xiao-Qun Han,Zuo-Jiong Gong.Ethyl pyruvate prevents inflammatory factors release and decreases intestinal permeability in rats with D-galactosamine-induced acute liver failure[J].Hepatobiliary & Pancreatic Diseases International,2013,12(2):180-188. 被引量:12
  • 2顾卫,谭峰,吴海科,王金良,万赛英,黄涛.清热解毒法治疗大、中等面积急性脑梗死及对CD_(62)P、TNF-α、IL-6活性的影响[J].中国中医急症,2006,15(8):809-810. 被引量:5
  • 3Boss B, McKendy K, Giaid A. Role of Urotensin II in health and disease[J]. Am J Physiol Regul Integr Comp Physiol, 2010, 298(5): R1156-1172.
  • 4Kiss RS, You Z, Genest J Jr, et al. Urotensin II differentially regulates macrophage and hepatic cholesterol homeostasis[J]. Peptides, 2011, 32(5): 956-963.
  • 5Watanabe T, Arita S, Shiraishi Y, et al. Human urotensin II promotes hypertension and atherosclerotic cardiovascular diseases[J]. Cur Med Chem, 2009, 16(5): 550-563.
  • 6Segain JP, Rolli Derkinderen M, Gervois N, et al. UrotensinII is a new chemotactic factor for UT receptor-expressing monocytes[J]. J Immunol, 2007, 179(2): 901-909.
  • 7Johns DG, Ao Z, Naselsky D, et al. Urotensin II-mediated cardiomyocyte hypertrophy effect of reeeptor antagonism and role of inflammatory mediators[J]. Naunyn Sehmiedebergs Arch Pharmaeol, 2004, 370(4): 238-250.
  • 8Cirillo P, de Rosa S, Pacileo M, et al. Human urotensin II induces tissue factor and cellular adhesion molecules expression in human coronary endothelial ceils: an emerging role for urotensin II in cardiovascular disease[J]. J Thromb Haemost, 2008, 6(5): 726-736.
  • 9Douglas SA, Ohlstein EH. Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease[J]. Trends Cardiovasc Med, 2000, 10(6): 229-237.
  • 10Leifeld L, Clemens C, Sauerbruch T, et al. Expression of urotensin II and its receptor in human liver cirrhosis and fulminant hepatic failure[J]. Dig Dis Sci, 2010, 55(5): 1458- 1464.

共引文献225

同被引文献30

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部